Free CME from PeerView


Oncology CME

Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
Petros Grivas, MD, PhD
December 01, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing Tides in Advanced Endometrial Cancer: A Visual Exploration of Current and Emerging Strategies to Maximize the Potential of Cancer Immunotherapies
Jubilee Brown, MD
November 30, 2021
Credits: 1.0 CME
Medical Learning Institute, Inc.
A New Wave of Progress in Glioblastoma: Expert Guidance on Delivering Modern Personalized Care With Tumor Treating Fields and Novel Systemic Approaches
Manmeet Ahluwalia, MD, MBA
November 20, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options
Nirav Shah, MD, MS
November 19, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC
David R. Jones, MD
November 19, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?
Jonathan W. Goldman, MD
November 18, 2021
Credits: 1 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?
Javid Moslehi, MD
November 15, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Harmonizing HCC Care With a Multidisciplinary Ensemble: Guidance for the Era of Novel Locoregional, Multimodal, and Systemic Strategies
Amit Singal, MD, MS
November 14, 2021
Credits: 1 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar in HR+/HER2- Early Breast Cancer: Multidisciplinary Strategies for Integrating the CDK4 and 6 Inhibitors
Joyce O’Shaughnessy, MD
November 08, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
Immunotherapy at the Cutting Edge in Resectable Esophageal/GEJ Cancer: Preparing Thoracic Surgeons and the Broader Multidisciplinary Team to Navigate Changing Standards of Care
Ronan J. Kelly, MD, MBA
November 04, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
Selecting and Sequencing Targeted and Immunotherapy Regimens for RCC: How Will the Latest Evidence Impact Treatment Decisions for My Patients?
Sumanta Kumar Pal, MD, FASCO
November 04, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team
October 29, 2021
Credits: 1 CME / MOC / CC
Medical Learning Institute, Inc.
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings
Lynette M. Sholl, MD
October 29, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Maintaining Vigilance to Mitigate Cancer Immunotherapy-Related Toxicities in the Emergency Department: Be Aware, Stay Alert, and Change Your Practice
Christopher Baugh, MD, MBA / Mark M. Awad, MD, PhD
October 25, 2021
Credits: 1 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Putting a Personalized Colorectal Cancer Treatment Algorithm Into Practice: Navigating Practicalities in the Era of Molecularly Defined Care
Prof Eric Van Cutsem, MD, PhD
October 14, 2021
Credits: 1.0 CME / MOC / NCPD
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
Anthony R. Mato, MD, MSCE
October 04, 2021
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
Sagar Lonial, MD, FACP
October 01, 2021
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD
September 29, 2021
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar for Patient Outcomes With Transcription Inhibition and Other New Options in the Treatment Arsenal for SCLC: Rationale, Mechanisms of Action, Latest Data, and Practicalities of Clinical Use in Oncology Practice
Jared Weiss, MD
September 29, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly Available and Innovative Therapeutics to Deliver Precision-Based Care
Milind Javle, MD
September 28, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Ushering in a New Wave of Progress in Advanced Hepatobiliary Cancers: Expert Perspectives on Incorporating New Evidence and Innovative Therapeutics to Deliver Optimal, Patient-Centered Care
Jackie Weatherly, PA-C
September 27, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
Kenneth R. Cooke, MD
September 24, 2021
Credits: 0.5 CME / MOC / CC
Medical Learning Institute, Inc.
Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and Treatment Principles
Sanam Loghavi, MD
September 20, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD
September 15, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD
September 10, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
September 09, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
Nicole Lamanna, MD
September 09, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
Ian W. Flinn, MD, PhD
September 07, 2021
Credits: 1 CME / MOC / CC / NCPD
PVI, PeerView Institute for Medical Education
Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical
September 02, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP
August 25, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView